Simon Sündermann

Dr. Simon Sündermann

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


28 August 2026 in European Heart Journal
Verified
Journal Article
Closed access
Maria BäckMaria Bäck
Maria Bäck
MWMatthias Wilhelm
Matthias Wilhelm
TMThimo Marcin
Thimo Marcin
FMFelipe Machado
Felipe Machado
ASAnna Sandberg
Anna Sandberg
GMGuzal Mullabayeva
Guzal Mullabayeva

9 July 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
MMMatteo Montagner
Matteo Montagner
MKMarkus Kofler
Markus Kofler
FSFabian Seeber
Fabian Seeber
LPLeonard Pitts
Leonard Pitts
CSChristoph Starck
Christoph Starck
JKJörg Kempfert
Jörg Kempfert
OBJECTIVES: A novel hybrid non-covered stent was developed to treat malperfusion and prevent aneurysm formation following hemiarch procedure for DeBakey I acute aortic dissection (AAD). The present analysis investigates the performance of the device in 100 consecutive implantations. METHODS: Between 2018 and 2021, 100 patients underwent surgical repair of DeBakey I AAD with implantation of a non-covered stent in the arch and descending aorta. The primary entry tear was located in the root or the ascending aorta. Clinical and imaging data were collected and analysed retrospectively. The endpoints of the study were 30-day mortality, neurological outcome and need of additional procedures due to postoperative malperfusion. Technical success was assessed in the first postoperative computed tomography in regard to the induction of false lumen thrombosis in the descending aorta. RESULTS: The median age was 61 (54–73) years. Preoperative malperfusion was present in 46 (46%) patients. The primary arterial cannulation strategy was the right axillary artery and an open distal anastomosis was performed in a median caudal circulatory arrest of 40 (34–52) min. In 48% of cases, a 55–40 tapered stent was implanted. The 30-day mortality was 18%, and the operation-related new postoperative neurological deficit was present in 8%. Technical success was achieved in 76% of patients. CONCLUSIONS: The novel non-covered stent can be safely applied to complement aortic repair with the hemiarch procedure for DeBakey I AAD. The expansion of the true lumen through the device may prevent postoperative malperfusion and induces positive vascular remodelling with the thrombosis of the false lumen.

1 December 2022 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
YHYuriy Hrytsyna
Yuriy Hrytsyna
SKSimon Kneissler
Simon Kneissler
FKFriedrich Kaufmann
Friedrich Kaufmann
MMMarcus Müller
Marcus Müller
FSFelix Schoenrath
Felix Schoenrath
JKJan Knierim
Jan Knierim

2 September 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
KPKarel M Van Praet
Karel M Van Praet
MKMarkus Kofler
Markus Kofler
SHSolveig Hirsch
Solveig Hirsch
SASerdar Akansel
Serdar Akansel
MHMatthias Hommel
Matthias Hommel
JKJörg Kempfert
Jörg Kempfert
OBJECTIVES: Analyses of fast-track (FT) processes demonstrated that low-risk cardiac surgical patients require minimal intensive care, with a low incidence of mortality or morbidity. We investigated perioperative factors and their association with fast-track failure (FTF) in a retrospective cohort study of patients undergoing minimally invasive mitral valve surgery. METHODS: Patients undergoing minimally invasive surgical mitral valve repair for Carpentier type I or type II mitral regurgitation between 2014 and 2020 were included in the study. The definition of FTF consisted of >10 h mechanical ventilation, >24 h intensive care unit stay, reintubation after extubation and re-admission to the intensive care unit. Multivariable logistic regression analysis enabled the identification of factors associated with FTF. RESULTS: In total, 491 patients were included in the study and were analysed. Two hundred and thirty-seven patients (48.3%) failed the FT protocol. Multivariable logistic regression analysis showed that a New York Heart Association classification ≥III [odds ratio (OR) 2.05; 95% confidence interval (CI) 1.38–3.08; P < 0.001], pre-existing chronic kidney disease (OR 2.03; 95% CI 1.14–3.70; P = 0.018), coronary artery disease (OR 1.90; 95% CI 1.13–3.23; P = 0.016), postoperative bleeding requiring surgical revision (OR 8.36; 95% CI 2.81–36.01; P < 0.001) and procedure time (OR 1.01; 95% CI 1.01–1.01; P < 0.001) were independently associated with FTF. CONCLUSIONS: Factors associated with FTF in patients with Carpentier type I and II pathologies undergoing minimally invasive mitral valve repair are a New York Heart Association classification III–IV at baseline, pre-existing chronic kidney disease and coronary artery disease. Postoperative bleeding requiring rethoracotomy and procedure time were also identified as important factors associated with failed FT.